The Dutch government is planning to classify strong strains of marijuana and cannabis as a Class A drug alongside heroin and cocaine. Coffee shops will only be able to offer cannabis with a THC level of below 15%. More details of the government's plans to drop the controversial membership scheme for coffee shops were also explained. While coffee shops will only be open to people with official documents which show they live in the Netherlands, it will be up to local authorities to decide how to introduce the new rules. (See also: Cannabis pass abolished? Not really)
A disabled veteran has told an appeals court that the department of veteran affairs policy on medical marijuana has caused him pain and significant economic harm, in a development campaigners say is a positive step in the battle to push for the drug's reclassification. Michael Krawitz, one of five plaintiffs involved in a legal case before the court of appeal for the District of Columbia Circuit, told the Guardian that the VA denied him pain treatment after they discovered he had been prescribed medical marijuana while abroad.
A medical marijuana advocate urged a federal appeals court to require the U.S. government to relax, or at least rethink, a more-than-40-year-old rule that treats marijuana as a highly dangerous drug with no medical value. Federal drug regulators "have failed to weigh the evidence" from a growing number of medical studies showing that marijuana is effective for relieving pain and nausea, said Joe Elford, counsel for Americans for Safe Access. (See also: Appeals Court hears case on medical value of marijuana)
Ruth Runciman, Chair of the UK Drug Policy Commission (UKDPC)
15 October 2012
Despite the successes of recent years, there are still approximately 2,000 drug-related deaths in the UKevery year. Nearly 400,000 people have serious drug problems and the annual cost to society is estimated to be about £15bn. There is little or no evidence to support much of current expenditure on law enforcement and education in schools. We spend billions a year without knowing if it does any good. In boom years this was objectionable; now it is unsustainable.
In the context of a fast changing and well documented market in legal highs, the case of khat (Catha edulis) provides an interesting anomaly. It is first of all a plant-based substance that undergoes minimal transformation or processing in the journey from farm to market. Secondly, khat has been consumed for hundreds if not thousands of years in the highlands of Eastern Africa and Southern Arabia. In European countries, khat use was first observed during the 1980s, but has only attracted wider attention in recent years.
Neuropathic pain affects between 5% and 10% of the US population and can be refractory to treatment. Opioids may be recommended as a second-line pharmacotherapy but have risks including overdose and death. Cannabis has been shown to be effective for treating nerve pain without the risk of fatal poisoning. The author suggests that physicians who treat neuropathic pain with opioids should evaluate their patients for a trial of cannabis and prescribe it when appropriate prior to using opioids. This harm reduction strategy may reduce the morbidity and mortality rates associated with prescription pain medications.
Medical marijuana advocates are hoping state governments can succeed where their efforts have failed by asking federal authorities to reclassify pot as a drug with medical use. Recently, Colorado became the fourth state to ask the U.S. Drug Enforcement Administration to reclassify marijuana as a narcotic in the same league as heavyweight painkillers including oxycodone. The governors of Washington and Rhode Island filed a formal petition with the agency in November, and Vermont signed onto that request shortly afterward.